Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

We Need 2C but Not 2B: Developing Serotonin 2C (5‐HT2C) Receptor Agonists for the Treatment of CNS Disorders
Jianjun Cheng, Alan P. Kozikowski
ChemMedChem (2015) Vol. 10, Iss. 12, pp. 1963-1967
Open Access | Times Cited: 19

Showing 19 citing articles:

The serotonergic system and cognitive function
Dubravka Švob Štrac, Nela Pivac, Dorotea Mück‐Šeler
Translational Neuroscience (2016) Vol. 7, Iss. 1, pp. 35-49
Open Access | Times Cited: 239
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
Liang Tan, Wenzhong Yan, John D. McCorvy, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 9841-9878
Closed Access | Times Cited: 122
Serotonin receptors in epilepsy: Novel treatment targets?
Jo Sourbron, Lieven Lagae
Epilepsia Open (2022) Vol. 7, Iss. 2, pp. 231-246
Open Access | Times Cited: 40
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
Use of Zebrafish Models to Boost Research in Rare Genetic Diseases
Lucie Crouzier, Élodie M. Richard, Jo Sourbron, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13356-13356
Open Access | Times Cited: 30
New pharmacological approaches in the treatment of schizophrenia
Józef Muszyński, Agnieszka Bienert, Rasha Wafaie Mahmoud Elsorady, et al.
Pharmacological Reports (2025)
Closed Access
Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists
Jianjun Cheng, John D. McCorvy, Patrick M. Giguère, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 21, pp. 9866-9880
Closed Access | Times Cited: 31
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications
Guiping Zhang, Jianjun Cheng, John D. McCorvy, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 14, pp. 6273-6288
Open Access | Times Cited: 23
Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands
Liang Tan, Qingtong Zhou, Wenzhong Yan, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 9, pp. 4579-4602
Closed Access | Times Cited: 18
Identification of dual role of piperazine-linked phenyl cyclopropyl methanone as positive allosteric modulator of 5-HT2C and negative allosteric modulator of 5-HT2B receptors
Kartikey Singh, Chandan Sona, Vikas Ojha, et al.
European Journal of Medicinal Chemistry (2018) Vol. 164, pp. 499-516
Closed Access | Times Cited: 18
Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT2C Receptor Agonists
Joseph Carpenter, Ying Wang, Gang Wu, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 14, pp. 6166-6190
Closed Access | Times Cited: 15
Identification of Novel 1-O-Substituted Aporphine Analogues as Potent 5-HT2C Receptor Agonists
Qi Mao, Bingjie Zhang, Wanwan Li, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 4, pp. 549-559
Closed Access | Times Cited: 12
2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design
Huiqiong Li, Jianjun Cheng
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 101, pp. 129654-129654
Closed Access | Times Cited: 1
Asymmetric syntheses of (R)-4-halo-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines, important 5-HT2C agonist precursors
Thomas O. Schrader, Xiuwen Zhu, Michelle Kasem, et al.
Tetrahedron Letters (2018) Vol. 59, Iss. 21, pp. 2030-2033
Closed Access | Times Cited: 7
Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism
Guiping Zhang, John D. McCorvy, Sida Shen, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111626-111626
Open Access | Times Cited: 6
Design, Synthesis and Biological Evaluation of Potent Antioxidant 1‐(2,5‐Dimethoxybenzyl)‐4‐arylpiperazines and N‐Azolyl Substituted 2‐(4‐Arylpiperazin‐1‐yl)
Haythem A. Saadeh, Mohammad Ahmad Khasawneh, Abdelouahid Samadi, et al.
ChemistrySelect (2017) Vol. 2, Iss. 13, pp. 3854-3859
Closed Access | Times Cited: 4
Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT2C receptor
Thomas O. Schrader, Xiuwen Zhu, Michelle Kasem, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 38, pp. 127872-127872
Closed Access | Times Cited: 1
Comparing the Use of Dopamine and Norepinephrine in Shock Treatment
Majid Jalalyazdi, Amir Reza Parvizian, Shahrzad Mohseny Abyaneh
Cardiovascular Pharmacology Open Access (2016) Vol. 5, Iss. 5
Open Access
Identification of Spiro[chromene-2,4′-piperidine]s as Potent, Selective, and Gq-Biased 5-HT2C Receptor Partial Agonists
Guangqian Jiang, Bingjie Zhang, Xiaoya Zhang, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 15, Iss. 1, pp. 99-106
Closed Access
Page 1

Scroll to top